Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC Patients

Improving the Early Detection of Lung Cancer by Combining Exosomal Analysis of Hypoxia With Standard of Care Imaging

NCT04629079 ·Status: UNKNOWN

Pronostic and Predictive Value of EMT in Localized Lung Cancer

NCT03509779 ·Status: RECRUITING

Prediction of Immunotherapeutic Effect of Advanced Non-small Cell Lung Cancer

NCT04427475 ·Status: UNKNOWN ·Phase: NA

Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer

NCT00897143 ·Status: WITHDRAWN

Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients

NCT01257308 ·Status: UNKNOWN

Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy

NCT03042221 ·Status: RECRUITING

Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC

NCT05641870 ·Status: UNKNOWN

Construction of Microfluidic Exosome Chip for Diagnosis of Lung Metastasis of Osteosarcoma

NCT05101655 ·Status: COMPLETED

Proteomics in Small Cell Lung Cancer

NCT05623956 ·Status: RECRUITING

Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer

NCT00340847 ·Status: COMPLETED

Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer Diagnosis

NCT03830619 ·Status: COMPLETED

Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New Biomarkers

NCT03658460 ·Status: COMPLETED

Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations

NCT05701787 ·Status: RECRUITING

Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK)

NCT01662635 ·Status: COMPLETED

PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification

NCT05049837 ·Status: RECRUITING

Lung Cancer Next Generation Sequencing Using the Oncomine Comprehensive Assay

NCT03558165 ·Status: COMPLETED

The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer

NCT02380196 ·Status: COMPLETED

Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.

NCT06167460 ·Status: RECRUITING

Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment

NCT06086587 ·Status: NOT_YET_RECRUITING

Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC

NCT02422628 ·Status: UNKNOWN

Methylation Level of SHOX2 in Endobronchial Ultrasound With Real-time Guided Transbronchial Needle Aspiration for Lung Cancer Staging

NCT01653002 ·Status: COMPLETED

CirculAting Tumor DNA in Patients DIagnosed With Lung Metastasis From Colorectal Cancer: candiDate Selection for Local AblaTive thErapy

NCT04704960 ·Status: UNKNOWN

Multicenter Clinical Research for Early Diagnosis of Lung Cancer Using Blood Plasma Derived Exosome

NCT04529915 ·Status: UNKNOWN

Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.

NCT03220230 ·Status: COMPLETED

Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer

NCT01517971 ·Status: COMPLETED